Information for "Which in turn Inotropic Medicine Dobutamine or even Milrinone Can be Clinically More potent from the Treating Postligation Heart Affliction inside Preterm Babies"
From EECH Central
Basic information
Display title | Which in turn Inotropic Medicine Dobutamine or even Milrinone Can be Clinically More potent from the Treating Postligation Heart Affliction inside Preterm Babies |
Default sort key | Which in turn Inotropic Medicine Dobutamine or even Milrinone Can be Clinically More potent from the Treating Postligation Heart Affliction inside Preterm Babies |
Page length (in bytes) | 3,624 |
Page ID | 1438618 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Nodehandle76 (Talk | contribs) |
Date of page creation | 11:40, 4 May 2024 |
Latest editor | Nodehandle76 (Talk | contribs) |
Date of latest edit | 11:40, 4 May 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |